Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
doxorubicin (Doxil) (2 trials)
ifosfamide (ifex) (2 trials)
imatinib (gleevec) (4 trials)
sargramostim (leukine) (1 trial)
pazopanib (votrient) (1 trial)
regorafenib (stivarga) (1 trial)
Endometrial Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 3)
Kidney Neoplasms (Phase 3)
Neoplasm Metastasis (Phase 3)
Pheochromocytoma (Phase 3)
Sarcoma (Phase 3)
Trials (7 total)
Trial APIs (6 total)